OSCR
Oscar Health Inc
$32.18+0.88%
Setup
Base breakout
Buy Zone
$31.3-$32.87
Sector
Healthcare Plans
Industry
Healthcare Plans
75
Recommendation
Extended
Hold
Setup may be valid but price is no longer in a clean buy zone.
OSCR chart
Loading chart…
Overall Quality75
RS Rating
87
relative strength
Fundamentals
71
Solid fund-Q
Volume Demand
82
-4% vs avg
Technical Setup
75
6/8 checks
Industry/Theme
91
Healthcare Plans
Trade Plan
Extended
Entry
$31.3
Entry Zone
$31.3-$32.87
Stop / Risk
$28.8
RS Rating
87
Volume confirmed
Yes
Targets
$37.56 / $39.13
Breakout · IBD Setup
4 ✓ 4 ✗
Entry $31.3–$32.87Stop $28.8Target $37.56 / $39.13
Market regimeRange
Quality75
RS Rating87
Above 50-MA+34.59%
Above 200-MA+80.36%
VolumeConfirmed
In Buy ZoneNo
Not extendedExtended
Invalidation · Close below stop
How this came together
75
MarketRange
SetupBase breakout
ConfidenceExperimental · not backtested
Fund-Q71 · Solid
StatusHold
Stock Data
52-Week Range11 – 32
Price % Chg YTD123.94%
Price % Chg 4wk52.22%
50-Day Avg Vol7.5 Mil
P/E Ratio—
Market Cap$9B
SectorHealthcare
IndustryHealthcare Plans
Company Fundamentals
EPS % Chg (Qtr)124.38%
Sales % Chg (Qtr)52.55%
EPS Growth 5y0.13%
Sales Growth 5y90.8%
Annual ROE-2.63%
Gross Margin—
Operating Margin0.08%
Net Margin-0.3%
Debt / Equity0.26
Setup levels
Current price
$32.18
Pivot
$31.3
Distance to buy
+0.4%
52-week range
10.69-32.06
Trigger evidence
No active trigger evidence available.
Financial health checks
3/5
Return on equity above 15%
ROE -2.63%
Net margin above 10%
Net margin -0.3%
EPS growing quarter on quarter
EPS q/q 124.38%
Sales growing quarter on quarter
Sales q/q 52.55%
Debt to equity below 1.0
D/E 0.26
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE-2.63%
vs sector -25.6%
Net margin-0.3%
vs sector -19.6%
Gross margin—
EPS growth q/q124.38%
vs sector +105.2%
Sales growth q/q52.55%
vs sector +31.4%
Debt / equity0.26
vs sector -0.46
Business quality
71
GradeSolid
EPS rating82
P/E—
Market cap$9B
IndustryHealthcare Plans
Technical checks
Über 50-MA
Pass
Über 200-MA
Pass
RS-Linie auf neuem Hoch
Pass
Volumen bestätigt
Pass
In Kaufzone
Fail
Nicht überextended
Fail
Über 21-EMA
Pass
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-06-30
Trigger date
—
Days on list
4
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.